Lee S - Search Results

1

The clinical relevance of a polygenic risk score for type 2 diabetes mellitus in the Korean population.

Kim NY, Lee H, Kim S, Kim YJ, Lee H, Lee J, Kwak SH, Lee S. Kim NY, et al. Among authors: lee h, lee j, lee s. Sci Rep. 2024 Mar 8;14(1):5749. doi: 10.1038/s41598-024-55313-0. Sci Rep. 2024. PMID: 38459065 Free PMC article.

2

Earlier Age at Type 2 Diabetes Diagnosis Is Associated With Increased Genetic Risk of Cardiovascular Disease.

Lee H, Choi J, Kim NY, Kim JI, Moon MK, Lee S, Park KS, Kwak SH. Lee H, et al. Among authors: lee s. Diabetes Care. 2023 May 1;46(5):1085-1090. doi: 10.2337/dc22-2144. Diabetes Care. 2023. PMID: 36939558 Free PMC article.

3

Factors for achieving target serum uric acid levels after initiating urate-lowering therapy in patients with gout: results from the ULTRA registry.

Do H, Choi HJ, Choi B, Son CN, Kim SH, Choi SR, Kim JH, Kim MJ, Shin K, Kim HO, Song R, Lee SW, Ahn JK, Lee SG, Lee CH, Son KM, Moon KW. Do H, et al. Sci Rep. 2023 Nov 22;13(1):20511. doi: 10.1038/s41598-023-47790-6. Sci Rep. 2023. PMID: 37993515 Free PMC article.

4

Clinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database.

Lee SG, Park GU, Moon YR, Sung K. Lee SG, et al. Int J Environ Res Public Health. 2020 Nov 18;17(22):8559. doi: 10.3390/ijerph17228559. Int J Environ Res Public Health. 2020. PMID: 33218161 Free PMC article.

5

Analysis of appropriate duration of colchicine prophylaxis to maximize the persistence of xanthine oxidase inhibitors as the first-line urate-lowering therapy in patients with gout using the Korean Health Insurance Review and Assessment Service database.

So MW, Kim AR, Lee SG. So MW, et al. Int J Rheum Dis. 2023 Sep;26(9):1770-1778. doi: 10.1111/1756-185X.14825. Epub 2023 Jul 10. Int J Rheum Dis. 2023. PMID: 37431263

6

Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects?

Lee SG, Kim JM, Lee SH, Kim KH, Kim JH, Yi JW, Jung WJ, Park YE, Park SH, Lee JW, Baek SH, Lee JH, Kim GT. Lee SG, et al. Korean J Intern Med. 2013 Mar;28(2):206-15. doi: 10.3904/kjim.2013.28.2.206. Epub 2013 Feb 27. Korean J Intern Med. 2013. PMID: 23526131 Free PMC article.

7

Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis.

So MW, Kim AR, Lee SG. So MW, et al. Rheumatol Ther. 2024 May 20. doi: 10.1007/s40744-024-00674-1. Online ahead of print. Rheumatol Ther. 2024. PMID: 38769252 Free article.

8

Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia.

Suh CH, Lee Y, Yoo SB, Quasny H, Navarro Rojas AA, Hammer A, Song YW, Kang YM, Cho CS, Park W, Kwok SK, Lee SG, Chung WT, Bae SC. Suh CH, et al. Int J Rheum Dis. 2024 Jan;27(1):e14997. doi: 10.1111/1756-185X.14997. Epub 2023 Dec 23. Int J Rheum Dis. 2024. PMID: 38140854 Clinical Trial.

9

Monthly Oral Ibandronate Reduces Bone Loss in Korean Women With Rheumatoid Arthritis and Osteopenia Receiving Long-term Glucocorticoids: A 48-week Double-blinded Randomized Placebo-controlled Investigator-initiated Trial.

Shin K, Park SH, Park W, Baek HJ, Lee YJ, Kang SW, Choe JY, Yoo WH, Park YB, Song JS, Lee SG, Yoo B, Yoo DH, Song YW. Shin K, et al. Clin Ther. 2017 Feb;39(2):268-278.e2. doi: 10.1016/j.clinthera.2017.01.008. Epub 2017 Feb 1. Clin Ther. 2017. PMID: 28161119 Clinical Trial.

10

Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis.

Shin K, Kwon HM, Kim MJ, Yoon MJ, Chai HG, Kang SW, Park W, Park SH, Suh CH, Kim HA, Lee SG, Lee CK, Bae SC, Park YB, Song YW. Shin K, et al. Korean J Intern Med. 2022 Sep;37(5):1061-1069. doi: 10.3904/kjim.2021.018. Epub 2021 Dec 13. Korean J Intern Med. 2022. PMID: 34883551 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128,079 results

Search Page